Achieving 400 Living Donor Liver Transplantations Annually During the COVID-19 Pandemic: A Single-Center Experience
Sung-Min Kim,Young-In Yoon,Deok-Bog Moon,Ki-Hun Kim,Chul-Soo Ahn,Tae-Yong Ha,Gi-Won Song,Dong-Hwan Jung,Gil-Chun Park,Woo-Hyoung Kang,Hwui-Dong Cho,Eunkyoung Jwa,Su-Min Ha,Byeong-Gon Na,Min-Jae Kim,Sang-Hoon Kim,Geunhyeok Yang,Rak-kyun Oh,Shin Hwang,Sung-Gyu Lee
DOI: https://doi.org/10.1016/j.transproceed.2023.12.005
IF: 1.014
2024-02-03
Transplantation Proceedings
Abstract:Background The COVID-19 pandemic has had a major impact on liver transplantation (LT) and living donor programs globally. Purpose In this study, we aimed to present the principles and strategies of our LT program during the pandemic period and describe its achievements. Basic Procedures We retrospectively reviewed the outcomes of 1417 LTs performed at Asan Medical Center, Seoul, Korea, from 2020 to 2022. Of these, 216 recipients who received transplants from deceased donors were excluded, and 1201 recipients who received transplants from 1268 live donors were included in the study, including 38 children <18 years old. Main Findings Among the 1201 living donor LT (LDLT) recipients, the most common indication for LT was unresectable hepatocellular carcinoma (315/1163, 27.1%) in adults and biliary atresia (29/38, 76.3%) in pediatric recipients. Emergency LDLT was performed in 40 patients (3.3%). The median model of end-stage liver disease and pediatric end-stage liver disease scores were 13.9 ± 7.2 and 13.8 ± 7.1, respectively. In-hospital mortality of recipients was higher than usual at 2.2%, but the cause of death was not related to COVID-19 infection. Of the 1268 live donors who underwent hepatectomy for liver donation, 660 (52.1%) underwent hepatectomy using a minimally invasive approach. Although 17 (1.3%) live donors experienced major complications, there were no serious life-threatening complications and no mortality. Conclusion Even in a pandemic era, a team with well-established infection control protocols, patient-tailored surgical strategies, and thorough perioperative care can maintain LDLT at a similar quantitative and qualitative level as in a non-pandemic era.
immunology,surgery,transplantation